McKesson Corporation (MCK)
| Market Cap | 89.44B |
| Revenue (ttm) | 359.05B |
| Net Income (ttm) | 3.30B |
| Shares Out | 125.11M |
| EPS (ttm) | 25.72 |
| PE Ratio | 27.79 |
| Forward PE | 19.18 |
| Dividend | $2.84 (0.40%) |
| Ex-Dividend Date | Jun 2, 2025 |
| Volume | 822,207 |
| Open | 720.00 |
| Previous Close | 721.75 |
| Day's Range | 706.03 - 726.58 |
| 52-Week Range | 464.42 - 731.00 |
| Beta | 0.49 |
| Analysts | Strong Buy |
| Price Target | 697.67 (-2.41%) |
| Earnings Date | May 8, 2025 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for MCK stock is "Strong Buy." The 12-month stock price forecast is $697.67, which is a decrease of -2.41% from the latest price.
News
McKesson Corporation Completes Acquisition of Core Ventures
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Venture...
McKesson: Sustained Rally Backed By Strong Financials
The stock price of McKesson has maintained a strong upward trend throughout multiple years because of its solid financial performance and dedicated investor support which creates a defensive investmen...
Our Top 10 High-Growth Dividend Stocks -- May 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson To Spin-Off Its Medical-Surgical Solutions Business
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical...
McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ET Company Participants Britt Vitalone - Chief Financial Officer Conference Call Participants Allen Lu...
McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy
I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8%...
McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Jeni Doming...
McKesson to spin off surgical supplies unit, forecasts strong annual profit
McKesson forecast fiscal 2026 profit largely above estimates on Thursday and said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug d...
McKesson to Spin Off Medical-Surgical Company
The pharmaceutical distributor said the new company would be a differentiated medical surgical supply and solutions business.
McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings
McKesson Corporation MCK will release its fourth-quarter financial results after the closing bell on Thursday.
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on ...
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...
McKesson Shares Rise Nearly 1% After Key Signal
MCK moves higher through the session after Alert
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology
IRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Registration Opens for Annual McKesson ideaShare Conference
IRVING, Texas--(BUSINESS WIRE)--Register to attend McKesson ideaShare, a premier community pharmacy annual education and networking event, in Nashville from July 10-13, 2025.
Sit Out The Crash With These 5 Dividend Stocks
Stocks plummeted by more than 10% last week after President Trump unveiled his new ‘reciprocal' tariff chart, with some heavy importers like Kohl's, Five Below, and Wayfair falling more than 20% on th...
3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock
The S&P 500's three top performers in 2025 boast characteristics that could help them weather a further sell off.
McKesson Shares Up Over 2% After Key Signal
MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns.
An aging U.S. population is increasing the demand for medication, and this company delivers.
McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leadi...
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025
I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs...
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
McKesson Keeps Growing, Eyeing Bigger Future
Health care product distributor McKesson Corporation (MCK) reports big earnings gains, eye care acquisition.